Zeiss/Optovue dispute resolved

Article

The intellectual property dispute between Carl Zeiss Meditec and Optovue has been resolved by the companies, ahead of the legal case reaching court.

The intellectual property dispute between Carl Zeiss Meditec and Optovue has been resolved by the companies, ahead of the legal case reaching court.

The disputes, which were pending in the Northern District of California and Massachusetts Superior Court, were filed by Optovue in June 2007, alleging trademark infringement.

Although full terms of the final settlement agreement remain confidential, it is understood that the companies have now reached an agreement on intellectual property licensing and protection.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.